Explore All Access
Check if your research matches the topics covered in Journal for ImmunoTherapy of Cancer?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Journal for ImmunoTherapy of Cancer : Impact Factor & More
eISSN: 2051-1426pISSN: 2051-1426
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Journal for ImmunoTherapy of Cancer Key Metrics
CiteScore 
14.3
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q1Oncology
SNIP
2.23
Topics Covered on Journal for ImmunoTherapy of Cancer
Cancer
Immunotherapy
Lung cancer
Immune checkpoint
Gene expression
Progression-free survival
Melanoma
Tumor growth
Overall survival
Body mass index
Phagocytosis
Antigen
Chemokine
Toxicity
Immune effector
Surgical resection
Chimeric antigen receptor
Antitumor immunity
Lung
Tumor microenvironment
Journal for ImmunoTherapy of Cancer Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2885 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Society for Immunotherapy of Cancer |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Journal for ImmunoTherapy of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal for ImmunoTherapy of Cancer
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x)
- 6 Mar 2019
- Journal for ImmunoTherapy of Cancer
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.
- 4 Nov 2016
- Journal for immunotherapy of cancer
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.
- 18 Oct 2016
- Journal for immunotherapy of cancer
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Acute visual loss after ipilimumab treatment for metastatic melanoma.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x)
- 6 Mar 2019
- Journal for ImmunoTherapy of Cancer
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.
- 4 Nov 2016
- Journal for immunotherapy of cancer
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.
- 18 Oct 2016
- Journal for immunotherapy of cancer
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Acute visual loss after ipilimumab treatment for metastatic melanoma.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction.
- 18 Oct 2016
- Journal for immunotherapy of cancer
Compare Similar Journals with Journal for ImmunoTherapy of Cancer
Select Journals to Compare with Journal for ImmunoTherapy of Cancer
Total journals - 8
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Cancers
Publisher: MDPI
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Annals of Oncology
Publisher: ELSEVIER
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Cancer Immunology Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Journal for ImmunoTherapy of Cancer
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Journal for ImmunoTherapy of Cancer
How long has Journal for ImmunoTherapy of Cancer been actively publishing? 
Journal for ImmunoTherapy of Cancer has been in operation since 2013 till date.
What is the publishing frequency of Journal for ImmunoTherapy of Cancer?
Journal for ImmunoTherapy of Cancer published with a Continuous publication frequency.
How many articles did Journal for ImmunoTherapy of Cancer publish last year?
In 2023, Journal for ImmunoTherapy of Cancer publsihed undefined articles.
What is the eISSN & pISSN for Journal for ImmunoTherapy of Cancer?
For Journal for ImmunoTherapy of Cancer, eISSN is 2051-1426 and pISSN is 2051-1426.
What is Citescore for Journal for ImmunoTherapy of Cancer?
Citescore for Journal for ImmunoTherapy of Cancer is 14.3.
What is SNIP score for Journal for ImmunoTherapy of Cancer?
SNIP score for Journal for ImmunoTherapy of Cancer is 2.23.
What is the SJR for Journal for ImmunoTherapy of Cancer?
SJR for Journal for ImmunoTherapy of Cancer is Q1.
Who is the publisher of Journal for ImmunoTherapy of Cancer?
BMJ PUBLISHING GROUP is the publisher of Journal for ImmunoTherapy of Cancer.
